| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |